Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01701414 · ClinicalTrials.gov registry record · Phase 2

Ultrasound-guided Femoral Nerve Blocks in Elderly Patients With Hip Fractures

A Phase 2 study of Hip Fractures and Femoral Neck Fractures, sponsored by Rhode Island Hospital.

Completed
Registry status
Phase 2
Development phase
38
Enrollment target
1
Study location

NCT01701414 is a Phase 2 study of Hip Fractures and Femoral Neck Fractures that has completed, run by Rhode Island Hospital. The registered enrollment target is 38 participants, below the 619-participant average among 15 other Hip Fractures trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01701414, a Phase 2 study of Hip Fractures and Femoral Neck Fractures, has completed, sponsored by Rhode Island Hospital.

COMPLETED
Registry status
Phase 2
Development phase
38 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if ultrasound guided femoral nerve blocks (localized anesthesia in the upper thigh) provide effective pain relief in adult patients with hip fractures in the emergency department and to determine if femoral nerve blocks can then be used to reduce the use of injected analgesia (anesthesia), therefore also causing fewer adverse effects associated with injected analgesia (such as bruising at the site of injection). 100 patients with hip fractures will be enrolled in the study. Patients will be randomly assigned to receive a femoral nerve block (FNB) plus injected analgesia or standard care (SC), which is injected analgesia alone. Using guidance from an ultrasound machine, the FNB group will have 20ml of 0.5% bupivacaine (a local anesthetic of long duration) injected into the front of the thigh, at the site of pain. Patients randomized to the SC group will receive an injection of saline (saltwater) so that no neither the patient or the treating physician knows to which group the patient was randomized. All blocks will be performed in the emergency department by an emergency physician trained in the use of ultrasound and ultrasound guided nerve blocks. Subjects will be asked to rate their pain on a numeric pain scale both before and after intervention (30 min, 60 min, 12 hrs and 24 hrs after injection, as long as the patient is in the ER still). Additional data to be collected includes demographics, vital signs, and course of treatment resulting from the ED visit. Hypothesis: US-guided femoral nerve blocks can provide effective pain control and possibly decrease or eliminate the need for narcotics.

Interventions

  • DRUG Femoral nerve block: 25 mL of 0.5% bupivacaine
  • DRUG Placebo: 3cc of 0.9% Normal Saline

Study Locations (1)

Rhode Island

  • Rhode Island Hospital - Providence

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2008-11
Est. Completion 2012-02
Phase Phase 2

Sponsor

Rhode Island Hospital

130 total trials

What the Registry Record Tells You About NCT01701414

The ClinicalTrials.gov registry entry for NCT01701414 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 619-participant average among 15 other Hip Fractures trials with a reported enrollment target (94% lower). The listed sponsor is Rhode Island Hospital, which has 130 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hip Fractures appearing as the primary indexed condition, and to 2 interventions - of which Femoral nerve block: 25 mL of 0.5% bupivacaine is the first listed.

NCT01701414 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.

Frequently Asked Questions

What is clinical trial NCT01701414 about?

NCT01701414 is a clinical study titled "Ultrasound-guided Femoral Nerve Blocks in Elderly Patients With Hip Fractures". The purpose of this study is to determine if ultrasound guided femoral nerve blocks (localized anesthesia in the upper thigh) provide effective pain relief in adult patients with hip fractures in the emergency department and to determine if femoral nerve blocks can then be used to reduce the use of ...

What is the current status of trial NCT01701414?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 38 participants. The study started on 2008-11. Estimated completion is 2012-02.

What conditions does trial NCT01701414 study?

This clinical trial studies the following conditions: Hip Fractures, Femoral Neck Fractures.

What interventions are being tested in trial NCT01701414?

The interventions under investigation include: Femoral nerve block: 25 mL of 0.5% bupivacaine (DRUG), Placebo: 3cc of 0.9% Normal Saline (DRUG).

Who is sponsoring clinical trial NCT01701414?

This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01701414 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hip Fractures

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.